Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review

被引:0
|
作者
Yu-Yu Jin
Fei-Hong Luo
机构
[1] Children’s Hospital of Fudan University,Department of Pediatric Endocrinology and Inherited Metabolic Diseases
[2] National Children’s Medical Center,undefined
来源
European Journal of Pediatrics | 2024年 / 183卷
关键词
Prader-Willi syndrome; Psychomotor development; Cognitive function; Language development; Mental and motor development; Growth hormone;
D O I
暂无
中图分类号
学科分类号
摘要
Prader-Willi syndrome (PWS) is a rare genetic disorder caused by the loss of imprinted gene expression on the paternal chromosome 15q11-q13. PWS is characterized by varying degrees of early psychomotor developmental deficits, primarily in cognition, language, and motor development. This review summarizes the early mental cognitive development, language development, and motor development in patients with PWS, compares the correlation of genotype with phenotype, and provides an update regarding the effects and concerns related to potential main side effects of treatment with recombinant human growth hormone on early psycho-cognitive and motor function development along with the linear growth and body composition of children with PWS.
引用
收藏
页码:1021 / 1036
页数:15
相关论文
共 50 条
  • [1] Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review
    Jin, Yu-Yu
    Luo, Fei-Hong
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (03) : 1021 - 1036
  • [2] Benefit of Early Commencement of Growth Hormone Therapy in Children with Prader-Willi Syndrome
    Nyunt, O.
    Harris, M.
    Hughes, I.
    Huynh, T.
    Davies, P. S. W.
    Cotterill, A. M.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2009, 22 (12): : 1151 - 1158
  • [3] Growth hormone therapy in children with Prader-Willi syndrome - Reply
    Carrel, Aaron L.
    Allen, David B.
    Moerchen, Victoria A.
    JOURNAL OF PEDIATRICS, 2006, 148 (06): : 846 - 847
  • [4] Growth hormone therapy in Prader-Willi Syndrome
    Davies, PSW
    INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (01) : 2 - 7
  • [6] Growth hormone therapy in the Prader-Willi syndrome
    Paterson, WF
    Donaldson, MDC
    ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (04) : 283 - 285
  • [7] Growth hormone treatment for Prader-Willi syndrome: A review
    Yang, Xin
    NEUROPEPTIDES, 2020, 83
  • [8] Psychomotor development in children with Prader-Willi syndrome. A case report
    Varvarousis, D. N.
    Stergiou, A. N.
    Christodoulou, P.
    ARCHIVES OF HELLENIC MEDICINE, 2021, 38 (06): : 791 - 794
  • [9] The use of growth hormone therapy in adults with Prader-Willi syndrome: A systematic review
    Frixou, Mikaela
    Vlek, Diane
    Lucas-Herald, Angela K.
    Keir, Lindsay
    Kyriakou, Andreas
    Shaikh, M. Guftar
    CLINICAL ENDOCRINOLOGY, 2021, 94 (04) : 645 - 655
  • [10] Review of growth hormone therapy in adolescents and young adults with Prader-Willi syndrome
    Lucas-Herald, Angela K.
    Perry, Colin G.
    Shaikh, M. Guftar
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (02) : 259 - 267